The Pezcoller Foundation-EACR Translational Cancer Researcher Award celebrates academic excellence and achievements in the field of translational cancer research. The award is presented annually to a researcher of excellence with no more than 15 years post-doctoral experience (or equivalent degree), with at least five years spent in Europe and presently employed in a European institution.
The winner gives the prestigious Pezcoller Foundation-EACR Translational Cancer Researcher Award Lecture at the EACR Congress. The next award will be presented at the EACR 2021 Virtual Congress to be held from 09-12 June 2021. As an invited speaker the award winner will receive a free registration to the Virtual Congress.
The award winner will receive a €10,000 honorarium. They will also be invited to give a lecture in Trento, Italy, at a date to be agreed, for which they will receive accommodation and travel costs.
Professor Andrea Ablasser obtained her MD at the University of Munich. After her post-doc at the University of Bonn, she joined the Swiss Federal Institute of Technology in Lausanne (EPFL) as an Assistant Professor in 2014. In 2019, she was promoted to Associate Professor at EPFL.
Her research focuses on mechanisms of innate immunity. She contributed to deciphering how cells respond to intracellular DNA as a signal of infection via the so-called cGAS-STING pathway - a fundamental discovery, which paved the way for promising new immunotherapies. Her lab has a strong interest in understanding of mechanisms that control cGAS-STING activity and how these mechanisms contribute to distinct pathologies, including cancer.
Amongst several distinctions, Andrea Ablasser is recipient of the Coley Award, the Sanofi-Institut Pasteur Award, the National Latsis Prize, the ACTERIA Prize, and the Eppendorf Award, and she is an elected member of EMBO. She is the founding scientist of IFM Due, a biopharmaceutical company developing cGAS-STING antagonists for the treatment of inflammatory disorders.
The Pezcoller Foundation is a non-profit institution, whose goal is to promote scientific research against diseases which afflict mankind, specifically the fight against cancer. The Founder, Prof. Alessio Pezcoller, was Chief Surgeon at Santa Chiara Hospital in Trento, Italy. The Foundation was established in 1980.
The Foundation depends primarily on the substantial sum of money bequeathed by Professor Alessio Pezcoller, and by significant contributions from its sponsors: the Cassa di Risparmio di Trento e Rovereto Foundation, the Province of Trento, the Administrative Councils of Trento and of Rovereto and other occasional private donations.
Due to its ever increasing recognition within the international oncological community, the Foundation collaborates with some of the most important cancer institutions: the American Association for Cancer Research (AACR) and the European Association for Cancer Research (EACR). The Pezcoller Awards are officially recognised during the international conferences of the two above mentioned associations.
This award was previously organised as the Pezcoller Foundation – EACR Cancer Researcher Award. Previous winners of the award:
2020: Nitzan Rosenfeld (University of Cambridge, UK and Inivata Ltd)
2018: Jan Korbel (EMBL Heidelberg, Germany)
2016: Yardena Samuels (MICC, Israel)
2014: Eduard Batlle (IRB Barcelona, Spain)
2012: Eric So (King's College London, UK)
The EACR is grateful for the continued support of its Industry Partners: